4.6 Article

A 1H NMR based metabonomics approach to progression of coronary atherosclerosis in a rabbit model

期刊

PROCESS BIOCHEMISTRY
卷 46, 期 12, 页码 2240-2247

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.procbio.2011.08.016

关键词

Coronary atherosclerosis; Metabonomics; Proton nuclear magnetic resonance (H-1 NMR); Multivariate statistical analysis; Rabbit

资金

  1. National Natural Science Foundation of China [81073021]
  2. Beijing Natural Science Foundation [7112093]
  3. National S&T Major Special Project on Major New Drug Innovation [2009ZX09301-003]

向作者/读者索取更多资源

Subtle metabolic variations precede and accompany oxidative and vascular damage, which correspond to the pathophysiological process of coronary heart disease (CHD). To investigate the progression of coronary atherosclerosis and identify potential biomarkers, the metabolic profiling in the plasma of rabbits fed a high-cholesterol diet were investigated using proton nuclear magnetic resonance spectroscopy (H-1 NMR) coupled with multivariate data analysis. Metabolite variations during atherogenesis showed a time-dependent development from physiological to pathophysiological status in rabbits. NMR-based plasma profiling demonstrated that low-density lipoprotein/very-low-density lipoprotein (LDL/VLDL), glutamine, phosphorylcholine, N-acetyl glycoproteins, betaine, proline, and tyrosine were the most positively corresponded metabolites of the aortic atherosclerotic lesions, whereas high-density lipoprotein (HDL), unsaturated lipids, citrate, glucose, and creatinine were the most negatively correlated metabolites. Multiple biochemical changes indicated dyslipidemia, oxidative stress, alteration of energy metabolism, and endothelial dysfunction after cholesterol overloading, and subsequently to early coronary atherosclerosis in rabbits. This study indicated that H-1 NMR based metabonomics can provide valuable information for the investigation of the dynamic biochemical variations underlying complex physiopathological conditions. It also offers a promising non-invasive means to the discovery of biomarkers for monitoring the onset and progression of CHD. (C) 2011 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据